作者单位：
Particle Sciences, Inc., Bethlehem, PA, United States
[1]
NCI Nanotechnology Alliance, National Cancer Institute, Bethesda, MD, United States
[2]
UNC Eshelman School of Pharmacy, UNC Institute for Pharmacogenomics and Individualized Therapy
[3]
Northeastern University, Bouvé College of Health Sciences, Department of Pharmaceutical Sciences
[4]
Nanotechnology Characterization Laboratory, SAIC-Frederick Inc., NCI-Frederick, Frederick, United
[5]
BIND Biosciences, Cambridge, United States
[6]
Division of NanoMedicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los
[7]
发布时间
2013-11-20
换一批
换一批
